The NFSA cell line, which is characterized by a high CCL11 expression, exhibited restricted angiogenesis and extensive necrosis, while the MS-K line with minimal CCL11 expression demonstrated robust tumor growth and well-developed vascular networks. The gene discussed is CCL11; the disease is neoplasm.